Tom Wilemon

May 11, 2021

New clinical guidance issued for people at increased cancer risk due to PALB2 gene variance

The American College of Medical Genetics and Genomics (ACMG) has released important new clinical practice guidance for the surveillance and treatment of patients with a gene variant that puts them at increased risk for cancer.

By Tom Wilemon
April 29, 2021

Grisanti receives VUMC Social Worker of the Year Award

Lindsay Grisanti, LMSW, is the recipient of the Carolyn Edwards Social Worker of the Year Award at Vanderbilt University Medical Center.

By Tom Wilemon
April 21, 2021

Zheng named VICC associate director for Population Sciences Research

Wei Zheng, MD, PhD, MPH, Anne Potter Wilson Professor of Medicine, has been named associate director for Population Sciences Research at Vanderbilt- Ingram Cancer Center (VICC).

By Tom Wilemon
April 15, 2021

Method proposed to correct misinterpretations of long-term survival rates for immunotherapies

Immune checkpoint inhibitors have transformed cancer care to the point where the popular Cox proportional-hazards model provides misleading estimates of the treatment effect, according to a new study published April 15 in JAMA Oncology.

By Tom Wilemon
April 8, 2021

VICC researchers featured at AACR Annual Meeting

Researchers from Vanderbilt-Ingram Cancer Center will have a robust presence during the first session of the American Association for Cancer Research (AACR) Annual Meeting, April 10-15, as presenters, panelists and authors.

By Tom Wilemon
April 6, 2021

Vanderbilt mourns the passing of Pierre Massion

Pierre Massion, MD, Cornelius Vanderbilt Chair and Professor of Medicine, an internationally known expert on early detection and prevention strategies for lung cancer, died April 4 of an apparent heart attack. He was 58.

By Tom Wilemon
March 26, 2021

Total skin electron therapy offered in Spring Hill

A radiation therapy device for the treatment of a rare cancer has been designed, custom built and installed at Vanderbilt-Ingram Cancer Center at Maury Regional Spring Hill, offering patients from Alabama, Mississippi, Georgia and southern Tennessee more convenient care.
By Tom Wilemon
March 25, 2021

Forty-three percent of melanoma patients have chronic complications from immunotherapies

Chronic side effects among melanoma survivors after treatment with anti-PD-1 immunotherapies are more common than previously recognized, according to a study published March 25 in JAMA Oncology.
By Tom Wilemon
March 25, 2021

Effort seeks to enroll more Black patients in lung cancer trials

Researchers from Vanderbilt University Medical Center are part of a multi-institutional study that aims to improve participation in lung cancer clinical trials among Black patients from Southern states.
By Tom Wilemon
March 18, 2021

Vanderbilt research played key role in new lung screen guidelines

The U.S. Preventive Services Task Force (USPSTF) has formally recommended two changes that will nearly double the number of people eligible for lung cancer screening by lowering the age from 55 to 50 and reducing the number of smoking history pack years from 30 to 20.
By Tom Wilemon
March 18, 2021

EGFR Resisters/LUNGevity fund lung cancer research

Christine Lovly, MD, PhD, associate professor of Medicine in the Division of Hematology and Oncology and Ingram Professor of Cancer Research, is one of two inaugural recipients of the EGFR Resisters/LUNGevity Lung Cancer Research Award.
By Tom Wilemon
March 9, 2021

Study incorporates genetics with smoking history to identify high-risk smokers for lung cancer screening

A study by Vanderbilt researchers that analyzed both smoking history and genetic risk variants for lung cancer supports modifying current guidelines to include additional smokers for lung cancer screening.
By Tom Wilemon
1 … 10 11 12 13 14 … 35